• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
KZR

KZR

Kezar Life Sciences, Inc.

NASDAQHealthcareBiotechnologyUS

USD7.29

+0.00 (+0.00%)

Company Profile

CEO

Christopher J. Kirk

IPO Date

2018-06-21

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$7.29

Prev. Close

$7.29

Day Low

$7.29

Day High

$7.29

52W Low

$3.53

52W High

$7.55

Market Cap

$0.05B

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

26.4%

Avg Negative

1.2%

Avg Neutral

72.5%

News Feed

Kezar Life Sciences to Participate in the William Blair Biotech Focus Conference 2021

Business Wire·7/8/2021·↑ positive

Kezar Life Sciences Announces Formation of Clinical Advisory Committee

Business Wire·6/8/2021·↑ positive

Kezar Presents Results of the Completed MISSION Phase 1b Study of KZR-616 at EULAR 2021

Business Wire·6/2/2021·↑ positive

Kezar Life Sciences to Participate in the Jefferies Virtual Healthcare Conference

Business Wire·5/27/2021·↑ positive

Kezar Life Sciences to Present at BIO CEO & Investor Digital Conference

Business Wire·2/10/2021·↑ positive

Kezar Life Sciences: Targeting The Immunoproteasome To Treat Autoimmunity

Seeking Alpha·1/28/2021·↑ positive

Kezar Life Sciences to Present at H.C. Wainwright Virtual BioConnect Conference

Business Wire·1/7/2021·↑ positive

Kezar Life Sciences: Keyed In On Autoimmune Therapies

Seeking Alpha·11/6/2020·↑ positive

Kezar Highlights Broad Therapeutic Potential of KZR-616 During ACR Convergence 2020

Business Wire·11/5/2020·↑ positive

Kezar Life Sciences (KZR) Investor Presentation - Slideshow

seekingalpha.com·9/11/2020·↑ positive